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In This IssueSemen Peptide Amyloids Enhance HIV Infection
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Globally, most infections with HIV/AIDS result from genital exposure to semen of HIV-positive men.
To identify novel factors affecting the efficiency of sexual HIV transmission, Mu¨nch et al. screened
a highly complex semen-derived peptide library. They show that fragments of the semen marker
prostatic acidic phosphatase (PAP) form amyloid fibrils that drastically enhance HIV infection.
Furthermore, they found that fibril-forming PAP fragments are abundant in seminal fluid and boost
semen-mediated enhancement of HIV infection. Thus, amyloid fibrils may play an important role in
sexual transmission of HIV and could represent new targets for its prevention.
Argonautes Steer microRNA Biogenesis
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microRNAs posttranscriptionally regulate the expression of many protein-coding genes and thus contribute to a wide variety of
physiological and pathological processes. Argonaute proteins are well-characterized effectors in microRNA- and siRNA-mediated
RNA interference. Diederichs and Haber now identify two additional roles for Argonaute proteins in microRNA processing and
regulation. They report that Argonaute proteins stabilize microRNA expression posttranscriptionally and that the mRNA-Slicer
Ago2 actively participates in microRNA processing by cleaving the pre-miRNA hairpin into a novel precursor, which they term
ac-pre-miRNA. Thus, Argonautes play vital roles in both microRNA biogenesis and function, marking them as coordinators of
the microRNA pathway.
Identifying microRNAs in Cancer-Initiating Cells
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Tumor-initiating cells are thought to be important for tumor metastases and to be resistant to conventional therapies and, thus, the
source of tumor recurrence. How self-renewal, multipotent differentiation, and tumorigenicity are maintained in these cells remains
obscure. Hypothesizing that microRNAs may be involved, Yu et al. analyzed microRNA expression in self-renewing and differen-
tiated cells from breast cancer lines generated by in vivo passage in immunodeficient mice under chemotherapy selection and in
breast tumor-initiating cells from primary breast cancers. They show that the evolutionarily conserved miRNA, let-7, regulates self-
renewal, multipotent differentiation, and the ability to form metastatic tumors that can be serially passaged as xenotransplants.
Malaria’s Great Escape Requires Regulated Proteolysis
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The most virulent form of malaria is caused by waves of replication of the unicellular parasite
Plasmodium falciparum in parasitophorous vacuoles (PV) within host erythrocytes. Rupture of the
infected blood cells releases merozoites (a process called egress), which invade fresh erythrocytes
to repeat the cycle. Themolecular events leading to egress are unknown. Now, Yeoh and coworkers
show that, just prior to egress, an essential protease called PfSUB1 is discharged from a parasite
organelle into the PV where it mediates the proteolytic maturation of members of the SERA family
proteases, also implicated in egress. Chemical inhibition of PfSUB1 activity impairs egress and
reduces the invasive capacity of released merozoites. These findings reveal a requirement for
regulated proteolytic processing in release of invasive parasites from the host erythrocyte.
Autophagy’s Debut in a New Role for Developmental
Cell Death
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Autophagy is a catabolic process that promotes cell survival under starvation conditions. Now Berry and Baehrecke provide phys-
iological evidence that autophagy also functions in cell death during development. The authors show that autophagy is induced
following growth arrest and precedes cell death of Drosophila salivary glands. Expression of growth regulators inhibits autophagy
and blocks salivary gland cell degradation in the presence of caspase proteases. Significantly, salivary gland degradation is
inhibited in autophagy gene (atg) mutants. This study indicates that multiple degradation pathways cooperate in cell clearance
during development.
Balancing Inclusion Bodies on a Scaffold
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Ubiquitin-positive inclusion bodies are a pathological hallmark of neurodegenerative diseases and liver injuries. Impairment of
either the ubiquitin-proteasome or autophagy-lysosome protein degradation pathways can lead to inclusion formation, but the
mechanisms by which inclusions are generated and the role of autophagy in these events are unclear. Komatsu et al. now report
that the autophagic degradation of the scaffold protein p62, via direct interaction with the autophagic protein LC3, prevents inclu-
sion body formation. Genetic ablation of p62 in autophagy-deficient micemarkedly attenuates liver injury, whereas it has little effect
on neuronal degeneration. Thus, a homeostatic level of p62, which is selectively regulated by autophagy, appears to control intra-
cellular inclusion body formation in a cell type-specific manner.Cell 131, December 14, 2007 ª2007 Elsevier Inc. 1019
Histone Ubiquitination Orients COMPASS for Methylation
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Histone H3 lysine 4 (H3K4) methylation is a hallmark of actively transcribing genes. The yeast
Set1/COMPASS complex is a histone H3K4 methylase with Cps35 being the only essential
subunit. Histone H2B monoubiquitination by Rad6/Bre1 is required for H3K4 methylation
by COMPASS. This mode of histone crosstalk is highly conserved from yeast to human but
mechanistically not well understood. Here, Lee et al. show that H2B ubiquitination regulates
the recruitment of the Cps35 to the COMPASS complex. This finding offers insight into the
molecular role of Cps35 in translating the H2Bmonoubiquitination signal into H3methylation.
A Complement for Synapse Elimination
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Precise neural circuits are sculpted in the developing brain by eliminating excess synapses.
Stevens et al. report that a part of the immune system, called the classical complement cas-
cade, is responsible for eliminating unwanted synapses. Using a mouse model of glaucoma,
they also find that the complement cascade becomes reactivated at adult retinal synapses early in the disease, followed by dra-
matic synapse loss. These findings provide a link between the activity of the immune system and neural development and suggest
that pharmacological inhibitors of the complement cascade may provide a promising new treatment for Alzheimer’s disease, glau-
coma, and amyotrophic lateral sclerosis.
Colorful Insights into Vertebrate Evolution
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Adaptation to new environments requires genetic changes that lead to the emergence of traits beneficial to survival in the new
niche. Stickleback fish andmodern humans have bothmigrated out of an ancestral location and colonizedmany newenvironments,
and both have developed diverse pigmentation traits. Miller et al. show that polymorphisms causing changes in the regulation of the
Stem Cell Factor gene underlie repeated evolution of pigmentation changes in new freshwater populations of sticklebacks, and
remarkably, regulatory changes in the same gene also contribute to changes in skin color among human groups. These findings
demonstrate that rapid evolution in very different organisms can occur through similar genetic mechanisms.
TAMping down Innate Immunity
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Infection by pathogens activates Toll-like receptors (TLRs) in dendritic cells and
macrophages triggering the production of inflammatory cytokines, including type
I interferons. Although important for pathogen clearance, this response must be
tightly regulated since unrestrained TLR signaling can lead to chronic inflammatory
disease, autoimmunity, and cancer. Rothlin et al. now show that TLR induction of
type I interferons leads to the engagement of the TAM receptor tyrosine kinases.
Activated TAMs then hijack type I interferon receptors to induce the cytokine
and TLR suppressors SOCS1 and SOCS3, thereby shutting down both TLR and
cytokine receptor signaling. TAM signaling thus provides an intrinsic feedback
inhibitor of the innate immune response.
Surveying Signaling Pathways in Lung Cancer
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Despite the success of tyrosine kinase-based cancer therapeutics, the kinases that drive cancer remain mostly unknown, thereby
limiting our ability to identify drug targets and predict response. Krikova et al. apply a global phosphoproteomic approach to
generate a detailed view of tyrosine kinase activity in lung cancer cell lines and tumors. Their analysis identifies multiple kinase
pathways activated in these tumors as well as novel oncogenic kinases. By focusing on activated kinases, this approach provides
insight beyond that presented by genome or transcriptome analyses. In addition the authors identify over 3900 new tyrosine phos-
phorylation sites, thereby providing a rich resource for future investigation.Cell 131, December 14, 2007 ª2007 Elsevier Inc. 1021
